RECURRENT GLIOBLASTOMA MULTIFORME TREATMENT MARKET ANALYSIS

Recurrent Glioblastoma Multiforme Treatment Market, by Treatment (Oral Medication, Radiosensitizers, Nitrosoureas Drugs, and Chemotherapy ), by Type (Grade II or Grade III, Grade IV, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Aug 2020
Code : CMI682
Pages :145
Formats :
Excel and PDF
Industry : Pharmaceutical

Recurrent Glioblastoma Multiforme Treatment MarketSize and Trends

The global recurrent glioblastoma multiforme treatment market is estimated to be valued at US$ 369.6 million in 2020 and is expected to exhibit a CAGR of 6.14% during the forecast period (2020-2027).

Recurrent Glioblastoma Multiforme Treatment Market Report Coverage

Forecast Period 2020 to 2027 CAGR:6.14%2027 Value Projection:US$ 560.9 MnGeographies covered:

Figure 1: Recurrent Glioblastoma Multiforme Treatment Market Share (%) Analysis, By Type, 2020

New drug approvals and launches for GBM treatme nt is expected to boost growth of the global recurrent glioblastoma multiforme treatment market